In a second study Kayagaki et al. (2023) treated WT mice with a NINJ1-antibody and used transgenic Ninj1fl/flRosa26-CreERT2 mice in the setting of different hepatitis models to better understand the role of NINJ1 in tissue injury. This evidence concerns the gene NINJ1 and hepatitis A virus infection.